- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Theoretical Calculations and Molecular Design of Novel Dioxoisoindoline Derivatives as Anticancer Agents. | ||
| Journal of University of Anbar for Pure Science | ||
| Volume 18, Issue 2, December 2024, Pages 103-111 PDF (723.81 K) | ||
| Document Type: Research Paper | ||
| DOI: 10.37652/juaps.2024.147172.1205 | ||
| Authors | ||
| Rawaa Mohammed Ahmed* 1; Mohammed Oday Ezzat2 | ||
| 1Department of Chemistry, College of Education for Pure Sciences, University of Anbar, | ||
| 2Department of Chemistry, College of Education for Women, University of Anbar, Ramadi, Anbar, Iraq. | ||
| Abstract | ||
| The decline in anticancer drugs is a constant problem in both basic and advanced medicine .It suggests using a theoretical chemical study to identify potential drugs using Dioxoisoindoline derivatives. The study utilized molecular docking and ΔG, comes to this conclusion. The chemical and protein more closely match when the negative G value is higher calculations to evaluate the derivatives' activity against cancer-related proteins. Several compounds, including S4, S1, and S1, demonstrated significant activity against different proteins. The ΔG values obtained for all derivatives fell within an acceptable range, indicating their potential as therapeutic agents. These findings suggest that the studied Dioxoisoindoline derivatives possess promising properties for targeting various cancer-related proteins. The text emphasizes the importance of developing alternative anticancer drugs and introduces a chemical study approach using these derivatives. The compounds tested showed promising activity against specific proteins, making them potential candidates for further research and development as potential anticancer medications. | ||
| Keywords | ||
| Dioxoisoindoline Derivatives; anticancer; Molecular modelling; docking affinity | ||
| References | ||
|
[1] Nussbaumer, S., Bonnabry, P., Veuthey, J. L., & Fleury-Souverain, S. (2011). Analysis of anticancer drugs: a review. Talanta, 85(5), 2265-2289.
[2] Sheikh Raisuddin, S. A., Fatima, M., & Dabeer, S. (2018). Toxicity of anticancer drugs and its prevention with special reference to role of garlic constituents. Annals of Phytomedicine, 7(1), 13-26.
[3] Singh, S., Sharma, B., Kanwar, S. S., & Kumar, A. (2016). Lead phytochemicals for anticancer drug development. Frontiers in plant science, 7, 1667.
[4] Iqbal, J., Abbasi, B. A., Mahmood, T., Kanwal, S., Ali, B., Shah, S. A., & Khalil, A. T. (2017). Plant-derived anticancer agents: A green anticancer approach. Asian Pacific Journal of Tropical Biomedicine, 7(12), 1129-1150.
[5] Choudhari, A. S., Mandave, P. C., Deshpande, M., Ranjekar, P., & Prakash, O. (2020). Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Frontiers in pharmacology, 10, 1614.
[6] Mathan, S. V., Rajput, M., & Singh, R. P. (2022). Chemotherapy and radiation therapy for cancer. In Understanding Cancer (pp. 217-236). Academic Press.
[7] Hnamte, M., & Pulikkal, A. K. (2024). Biocompatible polymeric nanoparticles as carriers for anticancer phytochemicals. EUROPEAN POLYMER JOURNAL, 202.
[8] Ekor, M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in pharmacology, 4, 177.
[9] Hnamte, M., & Pulikkal, A. K. (2023). Biocompatible polymeric nanoparticles as carriers for critical anticancer phytochemicals. European Polymer Journal, 112637.
[10] Crespo‐Otero, R., Li, Q., & Blancafort, L. (2019). Exploring potential energy surfaces for aggregation‐induced emission—from solution to crystal. Chemistry–An Asian Journal, 14(6), 700-714.
[11] Shi, Y., & Szlufarska, I. (2020). Wear-induced microstructural evolution of nanocrystalline aluminum and the role of zirconium dopants. Acta Materialia, 200, 432-441.
[12] Meng, X. Y., Zhang, H. X., Mezei, M., & Cui, M. (2011). Molecular docking: a powerful approach for
structure-based drug discovery. Current computer-aided drug design, 7(2), 146-157. | ||
|
Statistics Article View: 675 PDF Download: 252 |
||